Mar 2, 2026 09:02AM

Mar 2, 2026 09:00AM

Feb 24, 2026 09:01AM

Feb 24, 2026 09:00AM

Feb 17, 2026 10:48AM

Feb 5, 2026 09:26AM

Feb 4, 2026 08:50AM Oncolytics receives FDA fast track for colorectal cancer treatment

Feb 4, 2026 08:50AM

Jan 15, 2026 04:01PM

Jan 14, 2026 10:39AM

Jan 14, 2026 09:00AM

Jan 12, 2026 10:14AM

Jan 12, 2026 09:01AM

Jan 12, 2026 09:00AM Oncolytics Biotech® Announces Updated Clinical Data from GOBLET Cohort 4 Demonstrating Activity of Pelareorep Plus Atezolizumab in Third-Line Anal Cancer

Jan 9, 2026 09:02AM

Jan 9, 2026 09:00AM

Jan 8, 2026 12:08PM

Jan 8, 2026 09:02AM

Jan 8, 2026 09:00AM

Jan 7, 2026 12:15PM

Jan 7, 2026 09:01AM Oncolytics Biotech adds three experts to gastrointestinal advisory board

Jan 7, 2026 09:00AM

Dec 16, 2025 12:18PM

Dec 16, 2025 09:01AM

Dec 16, 2025 09:00AM

Dec 15, 2025 10:54AM

Dec 12, 2025 10:47AM

Dec 12, 2025 10:31AM GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era

Dec 9, 2025 06:01PM

Dec 9, 2025 06:00PM

Dec 6, 2025 01:51PM

Dec 3, 2025 03:31PM

Dec 3, 2025 12:51PM

Nov 20, 2025 04:07PM

Nov 20, 2025 04:05PM Oncolytics Biotech® Provides Update on Special Meeting of Shareholders

Nov 19, 2025 09:45AM

Nov 19, 2025 09:01AM

Nov 19, 2025 09:00AM

Nov 17, 2025 06:52AM

Nov 4, 2025 08:00AM

Nov 4, 2025 08:00AM

Oct 28, 2025 07:30AM Oncolytics reports 30% response rate in anal cancer trial

Oct 28, 2025 07:30AM

Oct 20, 2025 09:00AM

Sep 29, 2025 08:31AM

Sep 29, 2025 08:30AM

Sep 16, 2025 07:01AM

Sep 16, 2025 07:00AM

Sep 8, 2025 07:01AM Oncolytics reports colorectal cancer trial data, plans regulatory talks

Sep 8, 2025 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All